세계의 시토신 시장 규모, 점유율 및 동향 분석 보고서 : 최종 용도별, 지역별 전망 및 예측(2023-2030년)

The Global Cytosine Market size is expected to reach $612.4 million by 2030, rising at a market growth of 9.2% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,124.51 Tonnes experiencing a growth of 8.4% (2019-2022).

The pharmaceutical industry's focus on developing antiviral and anticancer drugs involves this comound and its derivatives. Cytosine-based compounds are integral in creating pharmaceutical agents that target specific genetic processes, contributing to the rising demand for this compound in these therapeutic areas. Consequently, the pharmaceutical segment would acquire nearly 65% of the total market share by 2030. Additionally, this compound is crucial for modifying and engineering DNA sequences used in gene therapies. As the pharmaceutical sector explores these cutting-edge treatments, the demand for this compound in gene therapy applications expands. Thus, the rising demand for pharmaceuticals, driven by ongoing research and the development of innovative therapies, significantly expands the market.

Advances in gene editing techniques, like CRISPR-Cas9, have revolutionized genetic engineering. This compound is a fundamental component in synthesizing guide RNA molecules used in CRISPR systems. The widespread adoption of CRISPR and other gene editing tools increases the demand for high-quality cytosine in research and therapeutic applications. Genomic medicine, which involves using information from an individual's genome to guide medical decisions, is an area where this compound plays a significant role. Advancements in genomic medicine, such as personalized treatments based on genetic profiles, contribute to the increased demand for this compound in diagnostics and targeted therapies. Thus, the expanding market is closely tied to the continuous advancements in biotechnology. Additionally, Government agencies often provide funding and grants to support biotechnology, genomics, and molecular biology research initiatives. This financial support encourages academic institutions, research organizations, and biotechnology companies to engage in compound-related projects. Collaborations between government entities and private industry players contribute to the growth of the market. Therefore, growing government support and regulatory frameworks provide a foundation for the expansion of the market.

However, this compound is a nucleotide base, and its synthesis involves intricate chemical processes. Achieving high purity and quality in production is essential for its use in various applications. The complexity of these synthesis and purification processes can drive up costs and pose challenges for manufacturers. State-of-the-art equipment and infrastructure are essential for efficient and high-throughput production of this compound. The initial investments in acquiring and maintaining specialized equipment, facilities, and technology can substantially impact the overall cost structure. Due to the above factors, market growth will be hampered in the coming years.

By End-Use Analysis

Based on end-use, the market is segmented into chemical industry, pharmaceutical, agriculture, and others. The agriculture segment acquired a substantial revenue share in the market in 2022. Agriculture is another major product end-user; it is one of the four nucleotide bases in DNA and plays a crucial role in crop improvement and breeding programs. Genetic variations and mutations in this compound & other nucleotide bases are essential for traditional crop breeding, allowing improved crop varieties with desirable traits, like disease resistance, increased yield, and enhanced nutritional content. Polymerase chain reaction (PCR), a widely used technique in molecular biology and genetics, allows for the amplification of specific DNA segments.

By Regional Analysis

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region held the highest revenue share in the market. This is attributed to the high product usage in various industries located in this region, including agriculture and pharmaceuticals. The pharmaceutical industry in North America has recognized the potential of this compound in drug discovery, development, and personalized medicine. The presence of leading biotechnology companies in North America fosters a culture of innovation and research excellence. Ongoing R&D initiatives in genetics, genomics, and personalized medicine drive the demand for this compound as a fundamental component in these scientific endeavors.

List of Key Companies Profiled

• Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
• VIVAN Life Sciences Pvt. Limited
• Tokyo Chemical Industry Co. Ltd.
• Santa Cruz Biotechnology, Inc.
• FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
• Central Drug House (P) Ltd.
• Naugra Export
• Marine Chemical

Global Cytosine Market Report Segmentation

By End-use (Volume, Tonnes, USD Million, 2019-2030)

• Pharmaceutical
• Agriculture
• Chemical Industry
• Others

By Geography (Volume, Tonnes, USD Million, 2019-2030)

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Cytosine Market, by End-use
  • 1.4.2 Global Cytosine Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Opportunities
  • 3.2.3 Market Restraints
  • 3.2.4 Market Challenges
• 3.3 Porter's Five Forces Analysis

Chapter 4. Global Cytosine Market, By End-use

• 4.1 Global Pharmaceutical Market, By Region
• 4.2 Global Agriculture Market, By Region
• 4.3 Global Chemical Industry Market, By Region
• 4.4 Global Others Market, By Region

Chapter 5. Global Cytosine Market, By Region

• 5.1 North America Cytosine Market
  • 5.1.1 North America Cytosine Market, By End-use
    • 5.1.1.1 North America Pharmaceutical Market, By Country
    • 5.1.1.2 North America Agriculture Market, By Country
    • 5.1.1.3 North America Chemical Industry Market, By Country
    • 5.1.1.4 North America Others Market, By Country
  • 5.1.2 North America Cytosine Market, By Country
    • 5.1.2.1 US Cytosine Market
      • 5.1.2.1.1 US Cytosine Market, By End-use
    • 5.1.2.2 Canada Cytosine Market
      • 5.1.2.2.1 Canada Cytosine Market, By End-use
    • 5.1.2.3 Mexico Cytosine Market
      • 5.1.2.3.1 Mexico Cytosine Market, By End-use
    • 5.1.2.4 Rest of North America Cytosine Market
      • 5.1.2.4.1 Rest of North America Cytosine Market, By End-use
• 5.2 Europe Cytosine Market
  • 5.2.1 Europe Cytosine Market, By End-use
    • 5.2.1.1 Europe Pharmaceutical Market, By Country
    • 5.2.1.2 Europe Agriculture Market, By Country
    • 5.2.1.3 Europe Chemical Industry Market, By Country
    • 5.2.1.4 Europe Others Market, By Country
  • 5.2.2 Europe Cytosine Market, By Country
    • 5.2.2.1 Germany Cytosine Market
      • 5.2.2.1.1 Germany Cytosine Market, By End-use
    • 5.2.2.2 UK Cytosine Market
      • 5.2.2.2.1 UK Cytosine Market, By End-use
    • 5.2.2.3 France Cytosine Market
      • 5.2.2.3.1 France Cytosine Market, By End-use
    • 5.2.2.4 Russia Cytosine Market
      • 5.2.2.4.1 Russia Cytosine Market, By End-use
    • 5.2.2.5 Spain Cytosine Market
      • 5.2.2.5.1 Spain Cytosine Market, By End-use
    • 5.2.2.6 Italy Cytosine Market
      • 5.2.2.6.1 Italy Cytosine Market, By End-use
    • 5.2.2.7 Rest of Europe Cytosine Market
      • 5.2.2.7.1 Rest of Europe Cytosine Market, By End-use
• 5.3 Asia Pacific Cytosine Market
  • 5.3.1 Asia Pacific Cytosine Market, By End-use
    • 5.3.1.1 Asia Pacific Pharmaceutical Market, By Country
    • 5.3.1.2 Asia Pacific Agriculture Market, By Country
    • 5.3.1.3 Asia Pacific Chemical Industry Market, By Country
    • 5.3.1.4 Asia Pacific Others Market, By Country
  • 5.3.2 Asia Pacific Cytosine Market, By Country
    • 5.3.2.1 China Cytosine Market
      • 5.3.2.1.1 China Cytosine Market, By End-use
    • 5.3.2.2 Japan Cytosine Market
      • 5.3.2.2.1 Japan Cytosine Market, By End-use
    • 5.3.2.3 India Cytosine Market
      • 5.3.2.3.1 India Cytosine Market, By End-use
    • 5.3.2.4 South Korea Cytosine Market
      • 5.3.2.4.1 South Korea Cytosine Market, By End-use
    • 5.3.2.5 Singapore Cytosine Market
      • 5.3.2.5.1 Singapore Cytosine Market, By End-use
    • 5.3.2.6 Malaysia Cytosine Market
      • 5.3.2.6.1 Malaysia Cytosine Market, By End-use
    • 5.3.2.7 Rest of Asia Pacific Cytosine Market
      • 5.3.2.7.1 Rest of Asia Pacific Cytosine Market, By End-use
• 5.4 LAMEA Cytosine Market
  • 5.4.1 LAMEA Cytosine Market, By End-use
    • 5.4.1.1 LAMEA Pharmaceutical Market, By Country
    • 5.4.1.2 LAMEA Agriculture Market, By Country
    • 5.4.1.3 LAMEA Chemical Industry Market, By Country
    • 5.4.1.4 LAMEA Others Market, By Country
  • 5.4.2 LAMEA Cytosine Market, By Country
    • 5.4.2.1 Brazil Cytosine Market
      • 5.4.2.1.1 Brazil Cytosine Market, By End-use
    • 5.4.2.2 Argentina Cytosine Market
      • 5.4.2.2.1 Argentina Cytosine Market, By End-use
    • 5.4.2.3 UAE Cytosine Market
      • 5.4.2.3.1 UAE Cytosine Market, By End-use
    • 5.4.2.4 Saudi Arabia Cytosine Market
      • 5.4.2.4.1 Saudi Arabia Cytosine Market, By End-use
    • 5.4.2.5 South Africa Cytosine Market
      • 5.4.2.5.1 South Africa Cytosine Market, By End-use
    • 5.4.2.6 Nigeria Cytosine Market
      • 5.4.2.6.1 Nigeria Cytosine Market, By End-use
    • 5.4.2.7 Rest of LAMEA Cytosine Market
      • 5.4.2.7.1 Rest of LAMEA Cytosine Market, By End-use

Chapter 6. Company Profiles

• 6.1 VIVAN Life Sciences Pvt. Limited
  • 6.1.1 Company Overview
• 6.2 Central Drug House (P) Ltd.
  • 6.2.1 Company Overview
• 6.3 Naugra Export
  • 6.3.1 Company Overview
• 6.4 Marine Chemical
  • 6.4.1 Company Overview
• 6.5 Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
  • 6.5.1 Company Overview
  • 6.5.2 SWOT Analysis
• 6.6 Tokyo Chemical Industry Co., Ltd.
  • 6.6.1 Company Overview
  • 6.6.2 SWOT Analysis
• 6.7 Santa Cruz Biotechnology, Inc.
  • 6.7.1 Company Overview
  • 6.7.2 SWOT Analysis
• 6.8 FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
  • 6.8.1 Company Overview
  • 6.8.2 Financial Analysis
  • 6.8.3 Segmental and Regional Analysis
  • 6.8.4 Research & Development Expenses
  • 6.8.5 SWOT Analysis

Chapter 7. Winning Imperatives of Cytosine Market